A Promising New Treatment Option for Congenital Generalized Lipodystrophy Table of Contents 1. A Promising New Treatment Option for Congenital Generalized Lipodystrophy 2. A Weekly
The Pediatric Transplant Advantage: A Looming Crisis for Young Adults on Dialysis A growing concern is emerging within the organ transplant community: a potential disadvantage
GLP-1 RA Therapy: Navigating Risks, Especially for Patients with Thyroid History Table of Contents 1. GLP-1 RA Therapy: Navigating Risks, Especially for Patients with Thyroid
A Shift in Coronary prevention: Declining Aspirin Use Among High-Risk Individuals Table of Contents 1. A Shift in Coronary prevention: Declining Aspirin Use Among High-Risk
The Hidden Barriers: Understanding Semaglutide Access for Obesity Patients Table of Contents 1. The Hidden Barriers: Understanding Semaglutide Access for Obesity Patients 2. Unlocking Access:
Pegloticase Shows Encouraging Safety Profile for Gout Treatment A new analysis of multiple clinical trials has found that pegloticase (Krystexxa; Amgen), a medication used to
The University of La laguna (ULL) marked a significant milestone last Saturday, bestowing its esteemed Honoris Causa doctorate upon four remarkable individuals. The honorees included
The Rising Tide of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the US Metabolic dysfunction-associated steatotic liver disease, commonly known as MASLD, is emerging as
© 2025 All rights reserved